Annual Drug Patent Expirations for DETECTNET
Detectnet is a drug marketed by Radiomedix and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has seven patent family members in six countries.
The generic ingredient in DETECTNET is copper dotatate cu-64. One supplier is listed for this compound. Additional details are available on the copper dotatate cu-64 profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com